Related Experiment Videos
Transformation studies with a human T-cell leukemia virus type 1 molecular clone
Matthew D Anderson1, Jianxin Ye, Li Xie
1Department of Veterinary Biosciences, The Ohio State University, 1925 Coffey Road, Columbus, OH 43210, USA.
Journal of Virological Methods
|January 24, 2004
Summary
Researchers developed a new method to generate stable cell lines expressing human T-cell leukemia virus type 1 (HTLV-1). This technique enables efficient infection of primary human T cells for studying HTLV-1 replication and transformation.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Human T-cell leukemia virus type 1 (HTLV-1) infection studies are limited by challenges in transfecting primary T cells and achieving efficient cell-free virus infection.
- Primary human T cells are the natural targets for HTLV-1, making them crucial for understanding viral replication and pathogenesis.
Purpose of the Study:
- To establish a reliable method for generating stable cell lines that express HTLV-1 from an infectious proviral clone.
- To facilitate the study of HTLV-1 replication and transformation in its natural target cells, primary human T lymphocytes.
Main Methods:
- Generation of stable cell lines by transfecting target cells with an infectious HTLV-1 proviral clone.
- Irradiation of stably transfected cells followed by co-culture with primary human peripheral blood mononuclear cells (PBMC).
- Characterization of resulting immortalized cell lines for integrated provirus, viral protein expression, and cellular markers.
Main Results:
- The method successfully generated stable cell lines expressing HTLV-1.
- Co-culture with irradiated cells led to efficient infection and immortalization of primary human PBMC.
- The immortalized cells exhibited characteristics of CD3+/CD4+ T cells, consistent with adult T-cell leukemia (ATL) phenotypes, and expressed a full spectrum of viral proteins.
Conclusions:
- The described method provides a powerful tool for studying HTLV-1 replication and transformation in primary human T lymphocytes.
- This approach overcomes previous limitations in infecting primary cells, enabling more accurate modeling of HTLV-1-associated diseases like ATL.